The largest database of trusted experimental protocols

Fusidic acid

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom

Fusidic acid is a laboratory reagent used for microbiological applications. It is a steroidal antibiotic that inhibits protein synthesis in bacteria. Fusidic acid is commonly used in microbiology research, diagnostic testing, and quality control procedures.

Automatically generated - may contain errors

12 protocols using fusidic acid

1

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibility testing of the isolated bacterial species was determined by Kirby-Bauer disk diffusion method22 except against vancomycin and polymyxin B where antimicrobial susceptibility was determined by the broth microdilution method.23 The selection of the antimicrobial agents was based on the type of the organism being tested, and the results were interpreted following the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial susceptibility Testing (EUCAST) interpretive criteria.24 ,25 The antibiotic disks included in the study were gentamicin 10 µg, piperacillin/tazobactam 100 µg/10 µg, imipenem 10 µg, meropenem 10 µg, cefazolin 30 µg, ceftazidime 30 µg, cefepime 30 µg, cefoxitin 30 µg, ciprofloxacin 5 µg, sulfamethoxazole/trimethoprim 23.75 µg/1.25 µg, tigecycline 15 µg, aztreonam 30 µg, chloramphenicol 30 µg, doxycycline 30 µg, fusidic acid 10 µg, clindamycin 2 µg, erythromycin 15 µg, linezolid 30 µg and quinupristin/dalfopristin 15 µg (All from Oxoid Ltd., Hampshire, UK).
+ Open protocol
+ Expand
2

Antibiotic Susceptibility Testing of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing was performed by disk diffusion method following the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. The tested antimicrobial agents were: cefoxitin (30 μg), gentamicin (10 μg), tetracycline (30 μg), trimethoprim-sulfamethoxazole (1.25/23.75 μg), erythromycin (15 μg), clindamycin (2 μg), ciprofloxacin (5 μg), mupirocin (200 μg), rifampicin (5 μg), fusidic acid (10 μg) and penicillin (1 μg) (all Oxoid, Basingstoke, UK). Isolates were classified as susceptible or resistant based on S. aureus epidemiological cut-off values issued by the EUCAST. erythromycin-induced clindamycin resistance was detected by Disk approximation test (D-test). The reference strain S. aureus ATCC 29213 was used as internal quality control. The nitrocefine test was completed using beta-lactamase identification sticks (Oxoid, Basingstoke, UK). The sizes of inhibition zone diameters were independently read by at least three operators and then averaged to obtain the final inhibition zone diameters (in mm).
+ Open protocol
+ Expand
3

Antibiotic Susceptibility Patterns

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic susceptibility patterns of bacteria to penicillin (P; 10 units), clindamycin (DA; 2 µg), chloramphenicol (C; 30 µg), gentamicin (CN; 10 µg), erythromycin (E; 15 µg), cefoxitin (FOX; 30 µg), sulfamethoxazole/trimethoprim (SXT; 1.25/23.75 µg), vancomycin (VA; 30 µg), rifampicin (RD; 5 µg), linezolid (LZD; 30 µg), mupirocin (MUP; 5 µg), ciprofloxacin (CIP; 5 µg), fusidic acid (FD; 10 µg), and novobiocin (NV; 5 µg) (Oxoid) were determined according to the antibiotic disk diffusion method (CLSI, 2014).
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility of C. difficile

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility tests were performed by the Kirby–Bauer disc diffusion method using Mueller–Hinton agar (HiMedia Laboratories, Mumbai, India, MV1084), according to the Clinical and Laboratory Standards Institute guidelines (19 ). After incubating the inoculated plate anaerobically at 37 °C for 2 days, the susceptibility of the C. difficile isolates against metronidazole (5 µg/disk), rifampicin (5 µg/disk), vancomycin (5 µg/disk), clindamycin (2 µg/disk), erythromycin (15 µg/disk), fidaxomicin (5 µg/disk), moxifloxacin (5 µg/disk), tigecycline (15 µg/disk), linezolid (30 µg/disk), fusidic acid (10 µg/disk) and tetracycline (30 µg/disk) antimicrobial agents (Oxoid, UK) was measured. Results were interpreted in accordance with interpretive criteria provided by CLSI (2012) (19 ). C. difficile ATCC 9689 was used as quality control organisms in antimicrobial susceptibility determination.
+ Open protocol
+ Expand
5

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard antibiotic susceptibility testing by the disc diffusion test was performed for cefoxitin (30 μg), fusidic acid (10 μg), erythromycin (15 μg), clindamycin (2 μg), trimethoprim/sulphamethoxazole (25 μg), gentamicin (10 μg), norfloxacin (10 μg), ciprofloxacin (5 μg), rifampin (5 μg) and vancomycin (5 μg) (all antibiotic discs from Oxoid, Basingstoke, Hampshire, England), with a 0.5 McFarland bacterial suspension in 0.85 % NaCl on Mueller–Hinton agar (Oxoid). After 16–20 h of incubation at 36 °C, the zone diameters were measured and each isolate was evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (http://www.eucast.org, accessed 2015-03-20).
Standard minimum inhibitory concentration (MIC) determination with the Etest (bioMérieux) was performed for vancomycin and teicoplanin on Mueller–Hinton agar (Oxoid) with a bacterial suspension adjusted to 0.5 McFarland in 0.85 % NaCl. The results were determined after 24 h of incubation at 36 °C, and, again, each isolate was evaluated according to EUCAST breakpoints.
Isolates resistant to ≥3 antibiotic groups tested were considered multidrug-resistant (MDR).
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility was done by Kirby-Bauer disk diffusion method8 (link) against a panel of antibiotics which included cefoxitin (30µg), linezolid (30µg), rifampin (5µg), fusidic acid (10µg), fosfomycin (50µg), tigecycline (15µg), tetracycline (30µg), chloramphenicol (30µg), ciprofloxacin (5µg), gentamicin (10µg), clindamycin (2µg), erythromycin (15µg), and sulfamethoxazole/trimethoprim (25µg) (Oxoid, UK). S. aureus ATCC 25923 was used as quality control strain. Results were interpreted according to the Clinical and Laboratory Standard Institute (CLSI) guidelines 2015. Minimum inhibitory concentrations (MICs) were performed for vancomycin (Sigma-Aldrich) using agar dilution method.9 (link)
+ Open protocol
+ Expand
7

Antibiotic Susceptibility of S. epidermidis in PJI

Check if the same lab product or an alternative is used in the 5 most similar protocols

S. epidermidis isolates (n = 183) were obtained during various surgical procedures due to suspected or verified PJI at the University Hospitals of Örebro and Linköping from 1999 to 2015 and from 1993 to 2015, respectively. The finding of S. epidermidis in multiple tissue samples (≥2) was interpreted as a PJI in accordance with the proposed definition of PJI [3 (link), 4 (link)]. Isolates were collected from patients with infected hip (n = 126), knee (n = 41), shoulder (n = 12), or elbow (n = 4) joint prostheses, then identified to the species level according to routine laboratory procedures and confirmed by MALDI-TOF MS (MicroflexLT and Biotyper 3.1, Bruker Daltonics, Bremen, Germany).
Standard antibiotic susceptibility testing by disc diffusion test (DDT) and MIC determination was performed according to EUCAST guidelines. MIC was determined by Etest for tedizolid, linezolid (Liofilchem, Roseto degli Abruzzi, Italy), and vancomycin (BioMérieux, Marcy-l’Etoile, France). DDT was performed for cefoxitin (30 μg), fusidic acid (10 μg), erythromycin (15 μg), clindamycin (2 μg), trimethoprim/sulfamethoxazole (25 μg), gentamicin (10 μg), norfloxacin (10 μg), and rifampin (5 μg) (Oxoid, Basingstoke, Hampshire, England).
+ Open protocol
+ Expand
8

Antibiotic Susceptibility Testing of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing (AST) of S. aureus isolates was performed by disc diffusion test according to EUCAST guidelines and the breakpoint table v.10.0 (2020)59 . The antibiotics tested were penicillin (10 µg), trimethoprim-sulfamethoxazole (25 µg), cefoxitin (30 µg), fusidic acid (10 µg), clindamycin (2 µg), erythromycin (15 µg), linezolid (10 µg), tetracycline (30 µg), norfloxacin (10 µg), ciprofloxacin (5 µg), gentamicin (10 µg) and rifampicin (5 µg) (Oxoid, Basingstoke, UK).
+ Open protocol
+ Expand
9

Antibiotic Susceptibility Patterns in Microbial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic susceptibility patterns of penicillin (P, 10 units), clindamycin (DA; 2 μg), chloramphenicol (C; 30 μg), gentamicin (CN; 10 μg), erythromycin (E; 15 μg), cefoxitin (FOX; 30 μg), sulfamethoxazole/trimethoprim (SXT; 1.25/23.75 μg), vancomycin (VA; 30 μg), rifampicin (RD; 5 μg), linezolid (LZD; 30 μg), mupirocin (MUP; 5 μg), ciprofloxacin (CIP; 5 μg), fusidic acid (FD; 10 μg) and novobiocin (NV; 5 μg) (Oxoid) were determined according to the antibiotic disk diffusion method [17 ]. The plates were incubated at 35°C for 24 hours. The zones of inhibition were determined whether the microorganism was susceptible, intermediately resistant, or resistant to each antibiotic.
+ Open protocol
+ Expand
10

Antibiotic Susceptibility Testing for PJI

Check if the same lab product or an alternative is used in the 5 most similar protocols
AST was performed by disc diffusion test according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (http://www.eucast.org) for the PJI isolates. The antibiotics tested were cefoxitin (30 µg), fusidic acid (10 µg), clindamycin (2 µg), erythromycin (15 µg), gentamicin (10 µg), rifampicin (5 µg), trimethoprim–sulfamethoxazole (25 µg) and norfloxacin (10 µg) (all discs from Oxoid). The clinical breakpoints were according to EUCAST recommendations (v9.0).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!